SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 276.9 CNY | +3.71% |
|
+6.67% | +51.87% |
| Apr. 26 | Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80% | MT |
| Apr. 25 | Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Companyâs main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-13
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
276.9
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +51.87% | 4.6B | |
| +8.05% | 72.03B | |
| -11.95% | 5.14B | |
| +3.92% | 3.96B | |
| -14.26% | 2.5B | |
| +20.42% | 2.43B | |
| -23.94% | 2.32B | |
| +20.02% | 2.18B | |
| +3.13% | 1.72B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 300573 Stock
- News Shenyang Xingqi Pharmaceutical Co.,Ltd.
- Xingqi Pharmaceutical Enrolls First Subject for Phase 4 Trial of Eye Drops